Hutch News

Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Study result moves scientists closer to developing elusive HIV vaccine
News Releases - May 24, 2023

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
13 NEW May 24, 2023
Optimizing antigen design may improve HIV vaccine efforts

Optimizing antigen design may improve HIV vaccine efforts

From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Science Spotlight - June 20, 2022
How do antibodies evolve to kill HIV-infected cells?

How do antibodies evolve to kill HIV-infected cells?

From the Overbaugh and Matsen labs, Human Biology and Public Health Sciences Division
Science Spotlight - February 15, 2021
All immunogens are not created equal

All immunogens are not created equal

From the Stamatatos lab, Vaccine and Infectious Disease Division
Science Spotlight - November 16, 2020
Benefits outweigh the social stigma of HIV vaccine trial participation

Benefits outweigh the social stigma of HIV vaccine trial participation

From the HIV Vaccine Trials Network and the University of Washington
Science Spotlight - July 20, 2020